Skip to main content
. 2017 Mar 21;3(2):51–62. doi: 10.1002/vms3.61

Table 1.

Reported canine germline coding variants in orthologs of known or candidate BC susceptibility genes

Gene rs§ Nomenclature Reference
Genomic* mRNA Protein
BRCA1 rs397510981 chr9:g.19985060 c.723A>G§ p.K241K (Enginler et al. 2014)
rs397512112 chr9:g.19985075 c.738T>A§ p.T246T (Enginler et al. 2014)
rs397509570 chr9:g.19988291 c.3954G>A p.S1318S (Borge et al. 2011)
BRCA2 rs23250374 chr25:g.7787056 c.428A>G p.H143R (Borge et al. 2011)
rs23244160 chr25:g.7775050 c.2401A>C p.K801Q (Borge et al. 2011)
c.2414G>A*** p.R805L (Hsu et al. 2010)
rs397511123 chr25:g.7768691_7768693 c.6918_6920delGTT p.L2307del (Borge et al. 2011; Enginler et al. 2014)
rs23255542 chr25:g.7768681 c.6930C>T§ p.F2310F (Rowell et al. 2011; Enginler et al. 2014)
rs397509895 chr25:g.7747589 c.9138A>G p.L3046L (Enginler et al. 2014)
chr25:g.7747332 c.9308A>G p.K3103R (Borge et al. 2011; Enginler et al. 2014)
rs397510884 chr25:g.7735440 c.9968G>A p.S3323N (Enginler et al. 2014)
rs853007536 chr25:g.7735654 c.9995_9996insAAA** p.M3332delinsIK (Yoshikawa et al. 2005; Borge et al. 2011; Enginler et al. 2014)
BRIP rs397511741 chr9:g.34983082 c.3029G>A p.R1010H (Borge et al. 2011)
rs397512960 chr9:g.34983223 c.3170C>T p.P1057L (Borge et al. 2011)
CDH1 chr5:g.80784440_80784442 c.387_389delCCA p.H129del (Borge et al. 2011)
rs397512866 chr5:g.80776897 c.945C>T p.S315S (Borge et al. 2011)
EGFR rs9206306 chr18:g.5996046 c.677G>A p.R226Q (Borge et al. 2011)
rs397513721 chr18:g.5996076 c.707C>T p.P236L (Borge et al. 2011)
HER2 (ERBB2) rs397510212 chr9:g.22773443 c.1105A>G p.K369E (Borge et al. 2011)
rs24616607 chr9:g.22770524 c.1575G>C p.P525P (Borge et al. 2011)
rs24537329 chr9:g.22770473 c.1626A>G p.E542E (Borge et al. 2011)
rs24537331 chr9:g.22770288 c.1728C>T p.C576C (Borge et al. 2011)
rs397510076 chr9:g.22766833 c.1905G>A p.A635A (Borge et al. 2011)
rs397512599 chr9:g.22763063 c.2769T>C p.Y923Y (Borge et al. 2011)
rs397512289 chr9:g.22761328 c.3486G>A p.P1162P (Borge et al. 2011)
rs397510013 chr9:g.22761055 c.3759C>T p.Y1253Y (Borge et al. 2011)
ESR1 rs21960513 chr1:g.42131190 c.627T>C p.F209F (Borge et al. 2011)
rs397512038 chr1:g.42208686 c.979A>G p.I327V (Borge et al. 2011)
rs397512133 chr1:g.42364093 c.1578G>A p.L526L (Borge et al. 2011)
PTEN chr26:g.37910150 c.975C>T p.L325L (Borge et al. 2011)
TP53 chr5:g.32564669 c.206C>T p.P69L (Veldhoen et al. 1999)
chr5:g.32564760_32562912 Germline deletion of exons 3‐7 (Veldhoen et al. 1999)

*Genome build: Broad CanFam3.1/canFam3 (Dog Assembly. Sept. 2011). Nucleotide accession numbers: BRCA1: NM_001013416.1, BRCA2: NM_001006653.4, BRIP: XM_847556.4, CDH1: NM_001287125.1, EGFR: ENSCAFT00000005575.3, HER2: NM_001003217.2, ESR1: NM_001286958.1, PTEN: NM_001003192, TP53: NM_000546.5. Protein accession numbers: BRCA1: NP_001013434, BRCA2: NP_001006654, BRIP: ENSCAFT00000045493.2, CDH1: NP_001274054.1, EGFR: ENSCAFT00000005575.3, HER2: NP_001003217, ESR1: NP_001273887.1, PTEN: NP_001003192, TP53: NP_001003210. §variants found only in CMT‐affected dogs. claimed to be associated with CMT. predicted to be pathogenic in respective papers. **variant was initially suspected pathogenic but is now considered neutral. ***variant is named as reported in Hsu et al.; due to lack of information presented, locating this variant within NM_001006653 and Broad CanFam3.1/canFam3 was not possible.